Intellia Therap

Forecast & Rating20 analysts currently cover Intellia Therap, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $26.17, about 143.9% upside from the current price of $10.73. Price targets range from $8.00 to $95.00 — a wide spread, showing clear disagreement over just how much Intellia Therap can rise. Historically, about 16.6% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Intellia Therap are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 18, 2026; for reference only and not investment advice.